Floris Wolswijk

Psychedelics Research Recap August 2020

Research slowed down a bit during this August, but still enough interesting things were found. The effect of 20 µg LSD on increasing pain tolerance was widely reported. This dosage is not psychedelic and not much above the ‘normal’ microdose range. More research on the pain-relieving (analgesic) effects of LSD in specific patient populations is the next logical step.

Psychedelics News August 2020

News about psychedelics hasn’t slowed down a bit during August. Everyone was delighted by the news that MAPS raised the $30 million they need to get MDMA-assisted psychotherapy through Phase III of FDA trials. Within a span of 6 months, they were able to raise this money from both large (from both aisles) and small donors (2700 in total).

Psychedelics Research Recap July 2020

Each month I’m surprised by the large number of studies done with ketamine, especially when compared to the small number of psilocybin and MDMA studies. This month also features some of those, one comparing ketamine unfavorably to ECT. Psychedelics for anxiety disorder and psilocybin specifically for OCD are also reviewed. A small study with MDMA in Brazil is reported, and exploratory research with 5-MeO-DMT and ibogaine see extraordinary results for trauma with veterans.

Scientific News

This page explains the process we take to digest scientific papers. This process is divided into three parts: selection, basic information, deeper exploration.

Trials Update

This page explains the process we take to digest new psychedelic trials. This process is divided into two parts: selection and adding information. 0. You can login here. 2. Adding Information 2.1 New Trial If you are finished with a trial, you can start again at the start of this sequence. 2.2 Updating Trial Many …

Read more

Psychedelics Research Recap June 2020

Psychedelic trials are getting larger and the data is still looking good. The long-term follow-up of Phase II MDMA for PTSD continues to show benefits at the one-year mark. A meta-analysis of nine placebo-controlled trials also showed strong improvements. And for the first time ketamine was studied on a population of treatment-resistant bipolar depression.

Psychedelics News July 2020

This month starts with a feature of Psychedelic Science Review which has ramped up their reporting and translation of scientific papers to understandable blogs. Companies in the psychedelic space continue to release news, but most of it is about acquisitions, not much is about trial outcomes.

Psychedelics News June 2020

As the world is still in partial lockdown, the psychedelics field seems to be evolving quicker than ever before. Much of the news below is related to the plans of companies. Some good news also comes from NGOs as MAPS is fundraising and support for psychedelics is growing in the US and Canda.